Advance Precision Oncology Programs with Discovery's Global Tissue Biomarker Services

We help our customers make confident decisions with a clear understanding of their target biomarkers using Discovery’s high-quality biospecimen solutions, genomic biomarker services, and an array of pathologist-driven histopathology services including IHC services delivered on all leading technology platforms (Dako, Ventana, Leica, TechMate).

See the impact of Discovery’s Tissue Biomarker Services impact for yourself.


Establishing HER2 As A Companion Diagnostic Biomarker For The Treatment Of Breast & Gastric Cancers


Development of the Prototype Immunohistochemistry Assay that Advanced Development of Pembrolizumab


Year Authors Title Journal PubMed ID Snippet Link